title: Can manipulation of splicing offer gene therapy possibilities to those with tumour-prone disorders?
authors.affiliation: Genetic Medicine, Manchester Academic Health Science Centre Central Manchester University Hospitals, NHS Foundation Trust, Manchester Royal Infirmary, Manchester, UK. gareth.evans@cmft.nhs.uk
authors.forename: D Gareth R
authors.initials: DG
authors.lastname: Evans
authors.forename: Andrew
authors.initials: A
authors.lastname: Wallace
authors.forename: William
authors.initials: W
authors.lastname: Newman
mesh_terms: D006801:Humans; D060172:Morpholinos / Q000008:administration & dosage*; D016518:Neurofibromatosis 2 / Q000235:genetics* / Q000628:therapy*; D025581:Neurofibromin 2 / Q000235:genetics*
chemical_list: D060172:Morpholinos; D025581:Neurofibromin 2